Pulmonary Arterial Hypertension

Low SES, Patient Barriers Hinder PAH Exercise Rehab

January 22nd 2021, 8:52pm


Lower socioeconomic status (SES) and barriers related to the perceived need for exercise rehabilitation were associated with decreased referral to rehabilitation among patients with pulmonary arterial hypertension (PAH).

Ensuring a Path of Success for Drug Repurposing in PAH

January 14th 2021, 9:15pm


Among the viewpoints offered by the authors to overcome barriers in solving unmet needs in pulmonary arterial hypertension (PAH) are preclinical pipelines for drug repurposing, working around challenges in early-stage trial design, and refining target selection and demonstration of engagement.

Identifying Predictors of Mortality for Adults With PAH, CHD

January 9th 2021, 11:30pm


A recent study sought to examine the course of these patients after the age of 40, and to identify possible risk factors for a worse prognosis.

Researchers Identify Predictors of Pulmonary Hypertension Among Patients With MPNs

December 29th 2020, 5:00am


Survival among patients with myeloproliferative neoplasm (MPN)–associated pulmonary hypertension (PH) is generally short, although the true prevalence of PH among these patients is poorly understood.

Sex, Genetics, and the Relationship Between the Two in Pulmonary Arterial Hypertension

December 26th 2020, 2:00pm


Although research has cemented BMPR2 mutations as having associations with the development of pulmonary arterial hypertension, the germline mutations are not the only culprit.

Researchers Outline Pathological Mechanisms, Potential Therapeutic Targets in PAH

December 22nd 2020, 2:30pm


In a new review, researchers outline both the underlying pathological mechanisms and potential therapeutic targets in pulmonary arterial hypertension (PAH).

Physicians’ Risk Assessment in Patients With PAH Often Varies From Objective Measures

December 17th 2020, 11:00am


In roughly half of cases assessed, physicians underestimated a patients’ risk, according to multiparametric objective risk-assessment tools.

Patients With PAH Fluctuate Between Feelings of Devastation and Hope

December 15th 2020, 2:00pm


In an abstract presented at CHEST 2020, investigators revealed that the emotions that patients with pulmonary arterial hypertension (PAH) regarding their illness are more complex than previously thought.

Review Analyzes Evidence Base for Multidrug Approach in PAH

December 12th 2020, 6:30pm


A review published earlier this year examines the rationale and evidence for using a multidrug approach in pulmonary arterial hypertension (PAH).

Studies Highlight Multiple Underlying Etiologies of PAH, Predictive Factors of PAA

December 10th 2020, 9:15pm


A group of researchers published their research on the various underlying etiologies of pulmonary arterial hypertension (PAH), as well as predictive factors of pulmonary artery aneurysms (PAAs).